Search

everythinglearnresearchcommunity

for

Search:↓

Obesity affects skin health, causing conditions like acanthosis nigricans and may require different treatment approaches.

PCOS affects about 4% of women in the southeastern U.S. equally across Black and White populations.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

Cyproterone acetate is effective for acne but less so for hirsutism and alopecia, with some side effects and quick menstrual cycle recovery after treatment.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

Too much male hormone is the main cause of Polycystic Ovary Syndrome.

Eating fewer calories, less sugar and refined carbs, and more low-glycemic and omega-3 rich foods can help manage PCOS symptoms.

Obesity increases the risk of developing polycystic ovary syndrome, and weight loss can improve the condition.

Eating 500 fewer calories a day and making lifestyle changes can improve PCOS symptoms and reduce diabetes risk; more research is needed on its causes and treatments.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Testosterone therapy seems safe for postmenopausal women for a few years, but more research is needed for long-term effects.

Menopause reduces skin collagen and elasticity, and while estrogen therapy can help, its risks require careful consideration.

Low-dose gonadotropin treatment is effective for infertility in women with PCOS, leading to high ovulation rates and comparable pregnancy rates with fewer complications.

Women with PCOS have different levels of certain fats and proteins in their blood, which could help diagnose the condition.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Minoxidil not effective in preventing chemotherapy-induced hair loss.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Birth control pills increase the risk of blood clots, especially within the first year and with certain types.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

Rutin may help treat symptoms of polycystic ovary syndrome (PCOS) in rats.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

A woman with breast cancer developed a rare condition causing excessive fine hair growth on her face and body.

Women with PCOS tend to have higher anxiety and depression levels compared to healthy women.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

Many women with PCOS have undiagnosed health issues and show different symptoms based on the clinic they visit.

Blocking the androgen receptor in skin cells reduces their growth response to male hormones, suggesting a possible treatment for skin conditions linked to androgens.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.